XML 43 R7.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Cash flows from operating activities:    
Net loss $ (7,964) $ (61,348)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 308 279
Reduction in the carrying amount of right-of-use assets 489  
Stock-based compensation expense 9,309 4,913
Loss on extinguishment of debt   181
Loss on disposal of fixed assets   13
Amortization of premium on short-term investments (881)  
Non Cash Interest Expense 512 219
Change in fair value of earn-out liabilities (82,734)  
Changes in operating assets and liabilities:    
Accounts receivable (12) (21)
Prepaid expenses and other current assets (2,037) (2,186)
Deposits   22
Prepaid expenses and other long-term assets 11 (11)
Accounts payable 387 1,480
Accrued expenses and other current liabilities (310) 3,034
Deferred rent and other long term liabilities (24) (284)
Operating lease liabilities (585)  
Deferred revenue 10 (273)
Net cash used in operating activities (83,521) (53,982)
Cash flows from investing activities:    
Acquisition of property and equipment (42) (65)
Capitalized software development costs   (427)
Purchases of short-term investments (111,174)  
Proceeds from maturities of short-term investments 30,000  
Net cash used in investing activities (81,216) (492)
Cash flows from financing activities:    
Proceeds from exercise of stock options 149 264
Proceeds from note payable 10,000 5,000
Proceeds from issuance of preferred stock, net issuance costs   109,681
Proceeds from business combination net of transaction costs paid 131,814  
Taxes paid related to net share settlement of share-based awards (28)  
Payment of debt issuance costs   (74)
Payment of premium on note payable   (26)
Repayment of principal on note payable   (2,000)
Net cash provided by financing activities 141,935 112,845
Net increase (decrease) in cash, cash equivalents, and restricted cash (22,802) 58,371
Cash, cash equivalents, and restricted cash at beginning of period 77,204 18,833
Cash, cash equivalents, and restricted cash at end of period 54,402 77,204
Supplementary Information:    
Cash paid for interest 834 217
Noncash investing and financing activities:    
Purchase of property and equipment included in accounts payable   7
Deferred asset for fees related to undrawn debt included in accrued expenses 51  
Common stock warrants issued related to note payable 282 268
Redemption value of Series D preferred stock 3,692 58,649
Dividends accrued for Series D preferred stock 7,383 $ 6,660
Recognition of liabilities for Earn-Out Shareholders 87,512  
Net liabilities assumed in the business combination $ 500